financetom
Business
financetom
/
Business
/
i-80 Gold Edging Lower In US Premarket Trade As Prices Upsized Offering of US$250 Million Convertible Senior Notes
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
i-80 Gold Edging Lower In US Premarket Trade As Prices Upsized Offering of US$250 Million Convertible Senior Notes
Mar 19, 2026 5:02 AM

07:36 AM EDT, 03/19/2026 (MT Newswires) -- i-80 GOLD CORP. ( IAUX ) was edging lower in US premarket trade after announcing Thursday that it has priced its previously announced offering of unsecured convertible senior notes due 2031.

The company in a statement said it intends to issue US$250 million aggregate principal amount of Notes (or US$287.5 million aggregate principal amount if the option granted to the initial purchasers to purchase additional Notes is exercised in full). The offering was upsized from a prior announced US$200 million (or US$230 million if the option granted to initial purchasers to buy additional Notes was exercised in full).

Thursday's statement noted the Notes will bear cash interest paid semi-annually at a rate of 3.75% per annum. The initial conversion rate for the Notes will be 519.4805 common shares of the company per US$1,000 principal amount of Notes, equivalent to an initial conversion price of approximately US$1.93 per Share. The initial conversion rate represents a premium of approximately 37.5% relative to yesterday's closing market price of the shares on the NYSE American and is subject to adjustment in certain events.

The offering is expected to close on or about March 23, 2026, subject to customary closing conditions including approval of the Toronto Stock Exchange and the NYSE American.

i-80 Gold ( IAUX ) said it intends to use the net proceeds from this offering to advance the company's gold projects through various stages of development, refurbish the Lone Tree processing plant, and fund resource expansion and infill drilling, as well as for general corporate and working capital purposes.

Shares in i-80 Gold ( IAUX ) were down 17.5% in Canada, and 13.5% in the U.S., yesterday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nationwide to acquire Allstate's stop-loss insurance business in $1.25 billion deal
Nationwide to acquire Allstate's stop-loss insurance business in $1.25 billion deal
Jan 30, 2025
Jan 30 (Reuters) - U.S. insurer Nationwide said on Thursday that it would acquire property and casualty insurer Allstate Corp's ( ALL ) employer stop-loss segment in a $1.25 billion deal, as it seeks to expand its stop-loss insurance offering. The transaction is expected to close in the second half of 2025, Nationwide said in a statement. Stop-loss insurance serves...
Apple shares rise after positive sales outlook signals iPhone recovery
Apple shares rise after positive sales outlook signals iPhone recovery
Jan 30, 2025
(Reuters) -Apple executives on Thursday forecast relatively strong sales growth, a sign the company will recover from a dip in iPhone sales as it rolls out artificial intelligence features. The forecast comes after Apple delivered a slight drop in iPhone revenues for the holiday shopping quarter and lagged Wall Street estimates, hampered by a lack in some markets of artificial...
Apple shares rise after positive sales outlook signals iPhone recovery
Apple shares rise after positive sales outlook signals iPhone recovery
Jan 30, 2025
(Reuters) -Apple executives on Thursday forecast relatively strong sales growth, a sign the company will recover from a dip in iPhone sales as it rolls out artificial intelligence features. The forecast comes after Apple delivered a slight drop in iPhone revenues for the holiday shopping quarter and lagged Wall Street estimates, hampered by a lack in some markets of artificial...
Biotech firm Maze Therapeutics raises $140 million in US IPO
Biotech firm Maze Therapeutics raises $140 million in US IPO
Jan 30, 2025
Jan 30 (Reuters) - Maze Therapeutics said on Thursday that it raised $140 million in an initial public offering, setting the stage for a debut that could make the kidney disease drug developer the first U.S. biotech listing this year. Maze priced the offering at $16 per share, within its indicated range of $15 to $17. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved